“because of the importance of this litigation, which is ongoing, and that it is important that Mr Tyschenko appreciates the importance of complying with orders of this court during a period when he may be involved in dealing with the disclosure order and other orders…”
“MR JUSTICE EDER But what happens… in a case where a Norwich Pharmacal Order is made and that it appears after compliance that because of the documents disclosed then, in compliance with the order, and further enquiry is then made, it is then discovered that the non-party against whom the original order was made is guilty of a tort or a crime or something like that? It seems odd that the applicant should not then be able to come back to the court and say ‘Now we have got the documents we know that this non-party is in fact involved in a crime or a tort or something of that kind and our losses include the costs that have been paid…I am making this order now…on the assumption that Mr Tyschenko is not involved in any fraud or tort or anything of that kind and that’s why I am prepared to make it, but it seems to me that Mr Akkouh is right, that if the underlying premise, which is the basis upon which I’m making that order, ultimately proves incorrect, that somehow or other I should deal with that….I’m keen that Mr Tyschenko gests his costs virtually automatically but I think Mr Akkouh is right…that although Totalise [a reference to a decision of the Court of Appeal which I consider in more detail below] may not deal with it expressly, I do think that I cannot and should not close the door in this kind of case from the possibility of Mr Akkouh coming back and saying, for whatever reason, on new evidence, new material, that that is-that order should be varied.”
“Rogly’s definitely not an Ablyazov company. I need to double-check with my financiers of course. I can tell you precisely that we never did any transfers to Ablyazov. I could never allow it”
“In accordance with paragraphs 7 and 8 of the Disclosure Order, the Claimant shall pay, on the qualified indemnity basis, the respondent’s legal costs, a reasonable allowance for the time the Respondent spends and the Respondent’s out of pocket expenses incurred relating to, preparing for and attending the further [cross-examination] up to the conclusion of the further [cross-examination].”
“Subject to agreeing suitable transfer documents, our client is willing to transfer such right and interest he (or his relevant companies) may have (if any) in the shares in…Medion and Logopark Tolmachevo…pursuant to an order providing for…Medion to be added to the receivership and directing the transfers to the receivers to be made…”
“So far as FinanceInvest LLC is concerned, our client does not believe that it is a company beneficially owned by Ablyazov…We have taken instructions from our client in relation to the evidence given by him during the cross-examination and he says that his evidence that it was owned by Ablyazov was mistaken…On that basis, our client’s position is that there is no basis for him to transfer the shares to the Receiver.”
“… I accepted [Mr Tyschenko’s] evidence and in reliance upon it adjourned the cross-examination of Mr Tyschenko. It now appears that on Wednesday of this week, when that statement was being put before me on behalf of Mr Tyschenko, he was not in Kiev meeting with Fortuna’s clients and creditors but was in Moscow, albeit on Fortuna business. It is plain that I was misled ….. If I ask myself whether I can trust Mr Tyschenko to obey the freezing order, in circumstances when he has permitted me to be told something which is plainly untrue, I am afraid that the answer is plain: I cannot.”
“My noble and learned friends, Lord Cross of Chelsea and Lord Kilbrandon, have dealt with the authorities. They are not very satisfactory, not always easy to reconcile and in the end inconclusive. On the whole I think they favour the appellants, and I am particularly impressed by the views expressed by Lord Romilly M.R. and Lord Hatherley L.C. in Upmann v. Elkan (1871) L.R. 12 Eq. 140; 7 Ch.App. 130. They seem to me to point to a very reasonable principle that if through no fault of his own a person gets mixed up in the tortious acts of others so as to facilitate their wrong-doing he may incur no personal liability but he comes under a duty to assist the person who has been wronged by giving him full information and disclosing the identity of the wrongdoers. I do not think that it matters whether he became so mixed up by voluntary action on his part or because it was his duty to do what he did. It may be that if this causes him expense the person seeking the information ought to reimburse him. But justice requires that he should co-operate in righting the wrong if he unwittingly facilitated its perpetration. I am the more inclined to reach this result because it is clear that if the person mixed up in the affair has to any extent incurred any liability to the person wronged, he must make full disclosure even though the person wronged has no intention of proceeding against him. It would I think be quite illogical to make his obligation to disclose the identity of the real offenders depend on whether or not he has himself incurred some minor liability. I would therefore hold that the respondents must disclose the information now sought unless there is some consideration of public policy which prevents that.”
“The full costs of the respondent of the application and any expense incurred in providing the information would have to be borne by the applicant.”
“29 We believe that Mr Higham is right. Norwich Pharmacal applications are not ordinary adversarial proceedings, where the general rule is that the unsuccessful party pays the costs of the successful party. They are akin to proceedings for pre-action disclosure where costs are governed byCPR r 48.3 . That rule, we believe, reflects the just outcome and is consistent with the views of Lord Reid and Lord Cross in the Norwich Pharmacal case[1974] AC 133 , 176, 199. In general, the costs incurred should be recovered from the wrongdoer rather than from an innocent party. That should be the result, even if such a party writes a letter to the applicant asking him to draw to the court's attention to matters which might influence a court to refuse the application. Of course such a letter would need to be drawn to the attention of the court. Each case will depend on its facts and in some cases it may be appropriate for the party from whom disclosure is sought to appear in court to assist. In such a case he should not be prejudiced by being ordered to pay costs. 30 The court when considering its order as to costs after a successful Norwich Pharmacal application should consider all the circumstances. In a normal case the applicant should be ordered to pay the costs of the party making the disclosure including the costs of making the disclosure. There may be cases where the circumstances require a different order, but we do not believe they include cases where: (a) the party required to make the disclosure had a genuine doubt that the person seeking the disclosure was entitled to it; (b) the party was under an appropriate legal obligation not to reveal the information, or where the legal position was not clear, or the party had a reasonable doubt as to the obligations; or (c) the party could be subject to proceedings if disclosure was voluntary; or (d) the party would or might suffer damage by voluntarily giving the disclosure; or (e) the disclosure would or might infringe a legitimate interest of another. 31 That does not mean that a party who supports or is implicated in a crime or tort or seeks to obstruct justice being done should believe that the court will do other than require that party to bear its costs and, if appropriate, pay the other party's costs.”